HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk of Type 2 Diabetes in Patients With Nonapnea Sleep Disorders in Using Different Types of Hypnotics: A Population-Based Retrospective Cohort Study.

Abstract
There has been insufficient evidence on whether exposure to hypnotics affects the risk of type 2 diabetes (T2DM). The aim of this study was to examine patients with nonapnea sleep disorders using zolpidem, benzodiazepines (BZDs), or a combination of both, and their risk of T2DM. This was a population-based retrospective cohort study using data from 1997 to 2011. Data from the Taiwan National Health Insurance Research Database were employed for this study. A total of 45,602 patients with nonapnea sleep disorders and use of hypnotics were identified as the study cohort. The control cohort comprised 40,799 age- and sex-matched patients. We conducted a Cox proportional hazard regression analysis to estimate the effects of hypnotics on risk of T2DM. The overall incidence of T2DM was 20.1 per 1000 person-years for patients using zolpidem, which was significantly higher than that of the control group (11.9 per 1000 person-years). Overall, patients with nonapnea sleep disorders using zolpidem had a higher risk of T2DM compared with patients not using zolpidem and the control cohort (adjusted hazard ratio [HR] = 1.41, 95% confidence interval [CI] = 1.35-1.48). We also observed a significantly higher risk of T2DM in patients with both zolpidem and BZD use (adjusted HR = 1.77, 95% CI = 1.64-1.91) than that of those without zolpidem use and BZD use. Compared with patients not using hypnotics, patients using zolpidem had a higher risk of developing T2DM; the risk was particularly pronounced in those using both zolpidem and BZDs.
AuthorsChia-Ling Lin, Mei-Chang Yeh, Tomor Harnod, Cheng-Li Lin, Chia-Hung Kao
JournalMedicine (Medicine (Baltimore)) Vol. 94 Issue 38 Pg. e1621 (Sep 2015) ISSN: 1536-5964 [Electronic] United States
PMID26402831 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hypnotics and Sedatives
  • Pyridines
  • Benzodiazepines
  • Zolpidem
Topics
  • Adult
  • Aged
  • Benzodiazepines (adverse effects)
  • Diabetes Mellitus, Type 2 (chemically induced)
  • Drug Interactions
  • Female
  • Humans
  • Hypnotics and Sedatives (adverse effects)
  • Male
  • Middle Aged
  • Pyridines (adverse effects)
  • Retrospective Studies
  • Risk Factors
  • Sleep Wake Disorders (complications, drug therapy)
  • Zolpidem

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: